Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2008 | 1 |
2009 | 1 |
2010 | 4 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Antiretroviral treatment 2010: progress and controversies.
J Acquir Immune Defic Syndr. 2010 Dec;55 Suppl 1(Suppl 1):S43-8. doi: 10.1097/QAI.0b013e3181f9c09e.
J Acquir Immune Defic Syndr. 2010.
PMID: 21045599
Free PMC article.
Two-year safety and virologic efficacy of maraviroc in treatment-experienced patients with CCR5-tropic HIV-1 infection: 96-week combined analysis of MOTIVATE 1 and 2.
Hardy WD, Gulick RM, Mayer H, Fätkenheuer G, Nelson M, Heera J, Rajicic N, Goodrich J.
Hardy WD, et al.
J Acquir Immune Defic Syndr. 2010 Dec 15;55(5):558-64. doi: 10.1097/QAI.0b013e3181ee3d82.
J Acquir Immune Defic Syndr. 2010.
PMID: 20703158
Free PMC article.
Clinical Trial.
Item in Clipboard
Early versus standard antiretroviral therapy for HIV-infected adults in Haiti.
Severe P, Juste MA, Ambroise A, Eliacin L, Marchand C, Apollon S, Edwards A, Bang H, Nicotera J, Godfrey C, Gulick RM, Johnson WD Jr, Pape JW, Fitzgerald DW.
Severe P, et al.
N Engl J Med. 2010 Jul 15;363(3):257-65. doi: 10.1056/NEJMoa0910370.
N Engl J Med. 2010.
PMID: 20647201
Free PMC article.
Clinical Trial.
Item in Clipboard
Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failure.
Paredes R, Lalama CM, Ribaudo HJ, Schackman BR, Shikuma C, Giguel F, Meyer WA 3rd, Johnson VA, Fiscus SA, D'Aquila RT, Gulick RM, Kuritzkes DR; AIDS Clinical Trials Group (ACTG) A5095 Study Team.
Paredes R, et al.
J Infect Dis. 2010 Mar;201(5):662-71. doi: 10.1086/650543.
J Infect Dis. 2010.
PMID: 20102271
Free PMC article.
Item in Clipboard
Response to vicriviroc in treatment-experienced subjects, as determined by an enhanced-sensitivity coreceptor tropism assay: reanalysis of AIDS clinical trials group A5211.
Su Z, Gulick RM, Krambrink A, Coakley E, Hughes MD, Han D, Flexner C, Wilkin TJ, Skolnik PR, Greaves WL, Kuritzkes DR, Reeves JD; AIDS Clinical Trials Group A5211 Team.
Su Z, et al.
J Infect Dis. 2009 Dec 1;200(11):1724-8. doi: 10.1086/648090.
J Infect Dis. 2009.
PMID: 19874179
Free PMC article.
Clinical Trial.
Item in Clipboard
Maraviroc for previously treated patients with R5 HIV-1 infection.
Gulick RM, Lalezari J, Goodrich J, Clumeck N, DeJesus E, Horban A, Nadler J, Clotet B, Karlsson A, Wohlfeiler M, Montana JB, McHale M, Sullivan J, Ridgway C, Felstead S, Dunne MW, van der Ryst E, Mayer H; MOTIVATE Study Teams.
Gulick RM, et al.
N Engl J Med. 2008 Oct 2;359(14):1429-41. doi: 10.1056/NEJMoa0803152.
N Engl J Med. 2008.
PMID: 18832244
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite